Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach.

Goss CW, O'Brian K, Dubray C, Fischer PU, Hardy M, Jambulingam P, King CL, Laman M, Lemoine JF, Robinson LJ, Samuela J, Subramanian S, Supali T, Weil GJ, Schechtman KB.

PLoS Negl Trop Dis. 2019 Jul 17;13(7):e0007541. doi: 10.1371/journal.pntd.0007541. [Epub ahead of print]

2.

Insecticide resistance status of Aedes aegypti and Aedes albopictus mosquitoes in Papua New Guinea.

Demok S, Endersby-Harshman N, Vinit R, Timinao L, Robinson LJ, Susapu M, Makita L, Laman M, Hoffmann A, Karl S.

Parasit Vectors. 2019 Jul 3;12(1):333. doi: 10.1186/s13071-019-3585-6.

3.

The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study.

Weil GJ, Bogus J, Christian M, Dubray C, Djuardi Y, Fischer PU, Goss CW, Hardy M, Jambulingam P, King CL, Kuttiat VS, Krishnamoorthy K, Laman M, Lemoine JF, O'Brian KK, Robinson LJ, Samuela J, Schechtman KB, Sircar A, Srividya A, Steer AC, Supali T, Subramanian S; DOLF IDA Safety Study Group.

PLoS Med. 2019 Jun 24;16(6):e1002839. doi: 10.1371/journal.pmed.1002839. eCollection 2019 Jun.

4.

Predictive factors for response and toxicity after brachytherapy for rectal cancer; results from the HERBERT study.

Rijkmans EC, Marijnen CAM, van Triest B, Ketelaars M, Cats A, Inderson A, van den Ende RPJ, Laman MS, Kerkhof EM, Nout RA.

Radiother Oncol. 2019 Apr;133:176-182. doi: 10.1016/j.radonc.2019.01.034. Epub 2019 Feb 18.

PMID:
30935576
5.

Contribution of Malaria to Inhospital Mortality in Papua New Guinean Children from a Malaria-Endemic Area: A Prospective Observational Study.

Laman M, Aipit S, Bona C, Aipit J, Davis TME, Manning L.

Am J Trop Med Hyg. 2019 Apr;100(4):835-841. doi: 10.4269/ajtmh.18-0769.

PMID:
30793683
6.

Efficacy and toxicity of chemoradiation with image-guided adaptive brachytherapy for locally advanced cervical cancer.

Horeweg N, Creutzberg CL, Rijkmans EC, Laman MS, Velema LA, Coen VLMA, Stam TC, Kerkhof EM, Kroep JR, de Kroon CD, Nout RA.

Int J Gynecol Cancer. 2019 Jan 10. pii: ijgc-2018-000057. doi: 10.1136/ijgc-2018-000057. [Epub ahead of print]

PMID:
30630883
7.

Antibody Targets on the Surface of Plasmodium falciparum-Infected Erythrocytes That Are Associated With Immunity to Severe Malaria in Young Children.

Chan JA, Boyle MJ, Moore KA, Reiling L, Lin Z, Hasang W, Avril M, Manning L, Mueller I, Laman M, Davis T, Smith JD, Rogerson SJ, Simpson JA, Fowkes FJI, Beeson JG.

J Infect Dis. 2019 Feb 15;219(5):819-828. doi: 10.1093/infdis/jiy580.

PMID:
30365004
8.

Acquisition of Antibodies Against Endothelial Protein C Receptor-Binding Domains of Plasmodium falciparum Erythrocyte Membrane Protein 1 in Children with Severe Malaria.

Rambhatla JS, Turner L, Manning L, Laman M, Davis TME, Beeson JG, Mueller I, Warrel J, Theander TG, Lavstsen T, Rogerson SJ.

J Infect Dis. 2019 Feb 15;219(5):808-818. doi: 10.1093/infdis/jiy564.

PMID:
30365003
9.

Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.

Tavul L, Hetzel MW, Teliki A, Walsh D, Kiniboro B, Rare L, Pulford J, Siba PM, Karl S, Makita L, Robinson L, Kattenberg JH, Laman M, Oswyn G, Mueller I.

Malar J. 2018 Oct 5;17(1):350. doi: 10.1186/s12936-018-2494-z.

10.

Electrocardiographic Safety of Repeated Monthly Dihydroartemisinin-Piperaquine as a Candidate for Mass Drug Administration.

Millat-Martínez P, Ila R, Laman M, Robinson L, Karunajeewa H, Abel H, Pulai K, Sanz S, Manning L, Moore B, Bassat Q, Mitjà O.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01153-18. doi: 10.1128/AAC.01153-18. Print 2018 Dec.

11.

Assessment of ultra-sensitive malaria diagnosis versus standard molecular diagnostics for malaria elimination: an in-depth molecular community cross-sectional study.

Hofmann NE, Gruenberg M, Nate E, Ura A, Rodriguez-Rodriguez D, Salib M, Mueller I, Smith TA, Laman M, Robinson LJ, Felger I.

Lancet Infect Dis. 2018 Oct;18(10):1108-1116. doi: 10.1016/S1473-3099(18)30411-0. Epub 2018 Aug 28.

PMID:
30170986
12.

Mathematical modelling of the impact of expanding levels of malaria control interventions on Plasmodium vivax.

White MT, Walker P, Karl S, Hetzel MW, Freeman T, Waltmann A, Laman M, Robinson LJ, Ghani A, Mueller I.

Nat Commun. 2018 Aug 17;9(1):3300. doi: 10.1038/s41467-018-05860-8.

13.

Validation of a Dried Blood Spot Ceftriaxone Assay in Papua New Guinean Children with Severe Bacterial Infections.

Mukap M, Sprod C, Tefuarani N, Laman M, Page-Sharp M, Salman S, Moore BR, Batty KT, Davis TME, Manning L.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e00940-18. doi: 10.1128/AAC.00940-18. Print 2018 Oct.

14.

Evaluation of clinical and endoscopic toxicity after external beam radiotherapy and endorectal brachytherapy in elderly patients with rectal cancer treated in the HERBERT study.

Rijkmans EC, van Triest B, Nout RA, Kerkhof EM, Buijsen J, Rozema T, Franssen JH, Velema LA, Laman MS, Cats A, Marijnen CAM.

Radiother Oncol. 2018 Mar;126(3):417-423. doi: 10.1016/j.radonc.2017.12.023. Epub 2018 Feb 3.

PMID:
29398154
15.

Methicillin-resistant Staphylococcus aureus in Papua New Guinea: a community nasal colonization prevalence study.

Laman M, Greenhill A, Coombs GW, Robinson O, Pearson J, Davis TME, Manning L.

Trans R Soc Trop Med Hyg. 2017 Aug 1;111(8):360-362. doi: 10.1093/trstmh/trx061.

PMID:
29237065
16.

The burden of presumed tuberculosis in hospitalized children in a resource-limited setting in Papua New Guinea: a prospective observational study.

Watch V, Aipit J, Kote-Yarong T, Rero A, Bolnga JW, Lufele E, Laman M.

Int Health. 2017 Nov 1;9(6):374-378. doi: 10.1093/inthealth/ihx043.

PMID:
29228220
17.

Ruthenium-106 brachytherapy for iris and iridociliary melanomas.

Marinkovic M, Horeweg N, Laman MS, Bleeker JC, Ketelaars M, Peters FP, Luyten GPM, Creutzberg CL.

Br J Ophthalmol. 2018 Aug;102(8):1154-1159. doi: 10.1136/bjophthalmol-2017-310688. Epub 2017 Nov 9.

PMID:
29122824
18.

Cost-effectiveness of artemisinin-naphthoquine versus artemether-lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children.

Moore BR, Davis WA, Clarke PM, Robinson LJ, Laman M, Davis TME.

Malar J. 2017 Oct 30;16(1):438. doi: 10.1186/s12936-017-2081-8.

19.

Benefit of adaptive CT-based treatment planning in high-dose-rate endorectal brachytherapy for rectal cancer.

van den Ende RPJ, Rijkmans EC, Kerkhof EM, Nout RA, Ketelaars M, Laman MS, Marijnen CAM, van der Heide UA.

Brachytherapy. 2018 Jan - Feb;17(1):78-85. doi: 10.1016/j.brachy.2017.08.011. Epub 2017 Sep 28.

20.

Safety and effectiveness of oral misoprostol for induction of labour in a resource-limited setting: a dose escalation study.

Morris M, Bolnga JW, Verave O, Aipit J, Rero A, Laman M.

BMC Pregnancy Childbirth. 2017 Sep 8;17(1):298. doi: 10.1186/s12884-017-1483-5.

21.

Maternal near-misses at a provincial hospital in Papua New Guinea: A prospective observational study.

Bolnga JW, Morris M, Totona C, Laman M.

Aust N Z J Obstet Gynaecol. 2017 Dec;57(6):624-629. doi: 10.1111/ajo.12650. Epub 2017 Jun 5.

PMID:
28580650
22.

Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.

Clarke GM, Rockett K, Kivinen K, Hubbart C, Jeffreys AE, Rowlands K, Jallow M, Conway DJ, Bojang KA, Pinder M, Usen S, Sisay-Joof F, Sirugo G, Toure O, Thera MA, Konate S, Sissoko S, Niangaly A, Poudiougou B, Mangano VD, Bougouma EC, Sirima SB, Modiano D, Amenga-Etego LN, Ghansah A, Koram KA, Wilson MD, Enimil A, Evans J, Amodu OK, Olaniyan S, Apinjoh T, Mugri R, Ndi A, Ndila CM, Uyoga S, Macharia A, Peshu N, Williams TN, Manjurano A, Sepúlveda N, Clark TG, Riley E, Drakeley C, Reyburn H, Nyirongo V, Kachala D, Molyneux M, Dunstan SJ, Phu NH, Quyen NN, Thai CQ, Hien TT, Manning L, Laman M, Siba P, Karunajeewa H, Allen S, Allen A, Davis TM, Michon P, Mueller I, Molloy SF, Campino S, Kerasidou A, Cornelius VJ, Hart L, Shah SS, Band G, Spencer CC, Agbenyega T, Achidi E, Doumbo OK, Farrar J, Marsh K, Taylor T, Kwiatkowski DP; MalariaGEN Consortium.

Elife. 2017 Jan 9;6. pii: e15085. doi: 10.7554/eLife.15085.

23.

A nurse-led sexual rehabilitation intervention after radiotherapy for gynecological cancer.

Bakker RM, Mens JW, de Groot HE, Tuijnman-Raasveld CC, Braat C, Hompus WC, Poelman JG, Laman MS, Velema LA, de Kroon CD, van Doorn HC, Creutzberg CL, Ter Kuile MM.

Support Care Cancer. 2017 Mar;25(3):729-737. doi: 10.1007/s00520-016-3453-2. Epub 2016 Oct 27.

24.

Ruthenium-106 brachytherapy for choroidal melanoma without transpupillary thermotherapy: Similar efficacy with improved visual outcome.

Marinkovic M, Horeweg N, Fiocco M, Peters FP, Sommers LW, Laman MS, Bleeker JC, Ketelaars M, Luyten GP, Creutzberg CL.

Eur J Cancer. 2016 Nov;68:106-113. doi: 10.1016/j.ejca.2016.09.009. Epub 2016 Oct 12.

PMID:
27741435
25.

Population genomics studies identify signatures of global dispersal and drug resistance in Plasmodium vivax.

Hupalo DN, Luo Z, Melnikov A, Sutton PL, Rogov P, Escalante A, Vallejo AF, Herrera S, Arévalo-Herrera M, Fan Q, Wang Y, Cui L, Lucas CM, Durand S, Sanchez JF, Baldeviano GC, Lescano AG, Laman M, Barnadas C, Barry A, Mueller I, Kazura JW, Eapen A, Kanagaraj D, Valecha N, Ferreira MU, Roobsoong W, Nguitragool W, Sattabonkot J, Gamboa D, Kosek M, Vinetz JM, González-Cerón L, Birren BW, Neafsey DE, Carlton JM.

Nat Genet. 2016 Aug;48(8):953-8. doi: 10.1038/ng.3588. Epub 2016 Jun 27.

26.

Naphthoquine: An Emerging Candidate for Artemisinin Combination Therapy.

Moore BR, Laman M, Salman S, Batty KT, Page-Sharp M, Hombhanje F, Manning L, Davis TM.

Drugs. 2016 May;76(7):789-804. doi: 10.1007/s40265-016-0572-5. Review.

PMID:
27075024
27.

Risk factors for Plasmodium falciparum and Plasmodium vivax gametocyte carriage in Papua New Guinean children with uncomplicated malaria.

Karl S, Laman M, Moore BR, Benjamin JM, Salib M, Lorry L, Maripal S, Siba P, Robinson LJ, Mueller I, Davis TM.

Acta Trop. 2016 Aug;160:1-8. doi: 10.1016/j.actatropica.2016.04.002. Epub 2016 Apr 4.

PMID:
27056132
28.

The Burden of Child Maltreatment Leading to Hospitalization in a Provincial Setting in Papua New Guinea.

Rero A, Aipit J, Yarong-Kote T, Watch V, Bolnga JW, Vei R, Morris M, Lufele E, Laman M.

J Trop Pediatr. 2016 Aug;62(4):282-7. doi: 10.1093/tropej/fmw001. Epub 2016 Feb 15.

PMID:
26884441
29.

A Toll-like receptor-1 variant and its characteristic cellular phenotype is associated with severe malaria in Papua New Guinean children.

Manning L, Cutts J, Stanisic DI, Laman M, Carmagnac A, Allen S, O'Donnell A, Karunajeewa H, Rosanas-Urgell A, Siba P, Davis TM, Michon P, Schofield L, Rockett K, Kwiatkowski D, Mueller I.

Genes Immun. 2016 Jan-Feb;17(1):52-9. doi: 10.1038/gene.2015.50. Epub 2015 Dec 3.

30.

Maternal and perinatal mortality in resource-limited settings.

Bolnga JW, Morris M, Aipit J, Laman M.

Lancet Glob Health. 2015 Nov;3(11):e672. doi: 10.1016/S2214-109X(15)00155-2. No abstract available.

31.

A decline of Haemophilus influenzae type b meningitis in Papua New Guinean children despite low vaccination coverage.

Lufele E, Aipit J, Siba P, Robinson LJ, Laman M.

J Trop Pediatr. 2015 Aug;61(4):313-4. doi: 10.1093/tropej/fmv040. Epub 2015 Jun 30. No abstract available.

PMID:
26130619
32.

Ultrasonographic assessment of splenic volume at presentation and after anti-malarial therapy in children with malarial anaemia.

Laman M, Aipit S, Bona C, Siba PM, Robinson LJ, Manning L, Davis TM.

Malar J. 2015 May 28;14:219. doi: 10.1186/s12936-015-0741-0.

33.

Gametocyte Clearance Kinetics Determined by Quantitative Magnetic Fractionation in Melanesian Children with Uncomplicated Malaria Treated with Artemisinin Combination Therapy.

Karl S, Laman M, Moore BR, Benjamin J, Koleala T, Ibam C, Kasian B, Siba PM, Waltmann A, Mueller I, Woodward RC, St Pierre TG, Davis TM.

Antimicrob Agents Chemother. 2015 Aug;59(8):4489-96. doi: 10.1128/AAC.00136-15. Epub 2015 May 18.

34.

Artemether-lumefantrine versus artemisinin-naphthoquine in Papua New Guinean children with uncomplicated malaria: a six months post-treatment follow-up study.

Laman M, Benjamin JM, Moore BR, Salib M, Tawat S, Davis WA, Siba PM, Robinson LJ, Davis TM.

Malar J. 2015 Mar 21;14:121. doi: 10.1186/s12936-015-0624-4.

35.

Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea.

Koleala T, Karl S, Laman M, Moore BR, Benjamin J, Barnadas C, Robinson LJ, Kattenberg JH, Javati S, Wong RP, Rosanas-Urgell A, Betuela I, Siba PM, Mueller I, Davis TM.

Malar J. 2015 Jan 28;14:37. doi: 10.1186/s12936-015-0560-3.

36.

Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial.

Laman M, Moore BR, Benjamin JM, Yadi G, Bona C, Warrel J, Kattenberg JH, Koleala T, Manning L, Kasian B, Robinson LJ, Sambale N, Lorry L, Karl S, Davis WA, Rosanas-Urgell A, Mueller I, Siba PM, Betuela I, Davis TM.

PLoS Med. 2014 Dec 30;11(12):e1001773. doi: 10.1371/journal.pmed.1001773. eCollection 2014 Dec.

37.

Viral pathogens in children hospitalized with features of central nervous system infection in a malaria-endemic region of Papua New Guinea.

Laman M, Hwaiwhanje I, Bona C, Warrel J, Aipit S, Smith D, Noronha J, Siba P, Mueller I, Betuela I, Davis TM, Manning L.

BMC Infect Dis. 2014 Nov 26;14:630. doi: 10.1186/s12879-014-0630-0.

38.

Prevalence of patients with acute febrile illnesses and positive dengue NS1 tests in a tertiary hospital in Papua New Guinea.

Asigau V, Lavu EK, McBride WJ, Biloh E, Naroi F, Koana E, Ferguson JK, Laman M.

Am J Trop Med Hyg. 2015 Jan;92(1):72-4. doi: 10.4269/ajtmh.14-0373. Epub 2014 Oct 20.

39.

Accuracy of cerebrospinal leucocyte count, protein and culture for the diagnosis of acute bacterial meningitis: a comparative study using Bayesian latent class analysis.

Manning L, Laman M, Mare T, Hwaiwhanje I, Siba P, Davis TM.

Trop Med Int Health. 2014 Dec;19(12):1520-4. doi: 10.1111/tmi.12400. Epub 2014 Oct 14.

40.

Malnutrition: a neglected but leading cause of child deaths in Papua New Guinea.

Aipit S, Aipit J, Laman M.

Lancet Glob Health. 2014 Oct;2(10):e568. doi: 10.1016/S2214-109X(14)70302-X. No abstract available.

41.

Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy.

Rijkmans EC, Nout RA, Rutten IH, Ketelaars M, Neelis KJ, Laman MS, Coen VL, Gaarenstroom KN, Kroep JR, Creutzberg CL.

Gynecol Oncol. 2014 Nov;135(2):231-8. doi: 10.1016/j.ygyno.2014.08.027. Epub 2014 Aug 27.

PMID:
25172763
42.

Comparison of three methods for detection of gametocytes in Melanesian children treated for uncomplicated malaria.

Karl S, Laman M, Koleala T, Ibam C, Kasian B, N'Drewei N, Rosanas-Urgell A, Moore BR, Waltmann A, Koepfli C, Siba PM, Betuela I, Woodward RC, St Pierre TG, Mueller I, Davis TM.

Malar J. 2014 Aug 14;13:319. doi: 10.1186/1475-2875-13-319.

43.

Accuracy of initial clinical diagnosis of acute bacterial meningitis in children from a malaria-endemic area of Papua New Guinea.

Aipit J, Laman M, Hwaiwhanje I, Bona C, Pomat N, Siba P, Davis TM, Manning L.

Trans R Soc Trop Med Hyg. 2014 Jul;108(7):444-8. doi: 10.1093/trstmh/tru067. Epub 2014 May 3.

PMID:
24794922
44.

Comparison of an assumed versus measured leucocyte count in parasite density calculations in Papua New Guinean children with uncomplicated malaria.

Laman M, Moore BR, Benjamin J, Padapu N, Tarongka N, Siba P, Betuela I, Mueller I, Robinson LJ, Davis TM.

Malar J. 2014 Apr 16;13:145. doi: 10.1186/1475-2875-13-145.

45.

Indications for Caesarean sections in a rural hospital in the Highlands of Papua New Guinea.

Mark TB, Radcliffe J, Laman M.

Trop Doct. 2014 Jul;44(3):171-2. doi: 10.1177/0049475514528899. Epub 2014 Mar 25.

PMID:
24667988
46.

Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.

Betuela I, Robinson LJ, Hetzel MW, Laman M, Siba PM, Bassat Q, Mueller I.

P N G Med J. 2014 Mar-Dec;57(1-4):68-74.

PMID:
26930890
47.

γδ T cells and CD14+ monocytes are predominant cellular sources of cytokines and chemokines associated with severe malaria.

Stanisic DI, Cutts J, Eriksson E, Fowkes FJ, Rosanas-Urgell A, Siba P, Laman M, Davis TM, Manning L, Mueller I, Schofield L.

J Infect Dis. 2014 Jul 15;210(2):295-305. doi: 10.1093/infdis/jiu083. Epub 2014 Feb 12.

48.

Clinical features and outcome in children with severe Plasmodium falciparum malaria: a meta-analysis.

Manning L, Laman M, Davis WA, Davis TM.

PLoS One. 2014 Feb 6;9(2):e86737. doi: 10.1371/journal.pone.0086737. eCollection 2014.

49.

Confirming cerebral malaria deaths in resource-limited settings.

Laman M, Davis TME, Manning L.

Am J Trop Med Hyg. 2014 Feb;90(2):192. doi: 10.4269/ajtmh.13-0280. No abstract available.

50.

Prevalence and implications of cerebrospinal fluid leukocytosis in Papua New Guinean children hospitalized with severe malaria.

Laman M, Manning L, Siba PM, Davis TM.

Am J Trop Med Hyg. 2013 Nov;89(5):866-8. doi: 10.4269/ajtmh.13-0281. Epub 2013 Sep 9.

Supplemental Content

Support Center